Type 2 & other diabetes

Plasma ALKAL2 levels are associated with coronary atherosclerosis in patients with type 2 diabetes mellitus

Cardiovasc DiabetolPublished Case-control study

Authors' conclusion

Elevated plasma ALKAL2 levels are an independent risk factor for T2DM CAD and are associated with the severity of CAD.

Study context

Population
Patients with T2D undergoing coronary angiography, Ruijin Hospital, January 2019 to December 2020age- and sex-matched
Participants
275 vs 275
Comparison
T2D patients with coronary artery disease (CAD) vs without CAD
  • CADn = 275
  • No CADn = 275reference
Outcome
Plasma ALKAL2 levels
Methodological detailsage- and sex-matched, single-centre, consecutive enrolment
  • Age- and sex-matched
  • Single-centre
  • Consecutive enrolment

Main finding

As reported in the abstract

P < 0.001

Observational data: associations, not effects.

Further findings

Correlation of ALKAL2 with CAD severity

Spearman rho
0.53, p < 0.001

Association of plasma ALKAL2 with CAD (multivariate logistic regression, adjusted for LDL-C, hsCRP and other traditional risk factors)

OR
2.24 (95% CI 1.79-2.85); p < 0.001

Original publication

Plasma ALKAL2 levels are associated with coronary atherosclerosis in patients with type 2 diabetes mellitus. Cardiovasc Diabetol. Published 8 October 2025. doi:10.1186/s12933-025-02948-6

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.